Results 141 to 150 of about 161,071 (201)

Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19. [PDF]

open access: yesJ Infect Dis
Attur M   +9 more
europepmc   +1 more source

Case report: Novel compound heterozygous IL1RN mutations as the likely cause of a lethal form of deficiency of interleukin-1 receptor antagonist. [PDF]

open access: yesFront Immunol
Urbaneja E   +11 more
europepmc   +1 more source

Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells [PDF]

open access: yes, 2019
Abou-Ezzi, Grazia   +17 more
core   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

Nature, 1990
Three interleukin-1 inhibitors have been purified to homogeneity from medium conditioned by human monocytes. Partial sequence analysis and digestion with N-glycanase indicate that these are glycosylation forms of a single protein. The protein binds to the interleukin-1 receptor but has no interleukin-1-like activity, even at very high concentrations ...
C H, Hannum   +9 more
exaly   +3 more sources

INTERLEUKIN-1 RECEPTOR ANTAGONIST

Rheumatic Disease Clinics of North America, 1998
There are three members of the IL-1 gene family: IL-1 alpha, IL-1 beta, and IL-1ra, IL-1 alpha, and IL-1 beta are both antagonist molecules with many proinflammatory effects. IL-1ra is an antagonist molecule that can inhibit the effect of IL-1 alpha and IL-1 beta by specifically blocking the IL-1 receptor on target effector cells.
B, Bresnihan, G, Cunnane
openaire   +2 more sources

Home - About - Disclaimer - Privacy